7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione Chemical Properties

Boiling point:

575.3±60.0 °C(Predicted)

Density 

1.43±0.1 g/cm3(Predicted)

storage temp. 

Refrigerator

pka

-1.40±0.40(Predicted)

form 

Solid

Appearance

Yellow to brown Solid

InChI

InChI=1S/C17H17N3O4/c21-13-6-7-20-15(16(13)24-10-12-4-2-1-3-5-12)17(22)19-8-9-23-11-14(19)18-20/h1-7,14,18H,8-11H2

InChIKey

HJTRSKVIYMCKJU-UHFFFAOYSA-N

SMILES

N12C=CC(=O)C(OCC3=CC=CC=C3)=C1C(=O)N1CCOCC1N2

7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione Usage And Synthesis

Uses

7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione is an intermediate of the antiviral drug baloxavir, which is used in the treatment of influenza A and B. It is used as an intermediate in the synthesis and manufacture of pharmaceuticals. It can be used as organic synthesis and pharmaceutical intermediates, mainly used in laboratory research and development and chemical production process of API synthesis research.

7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione(1370250-39-7)Related Product Information

• Zoledronic acid
• Zofluza intermediate
• Baloxavir Impurity 5
• (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
• (R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione
• Baloxavir
• Baloxavir marboxil
• 7,8-difluorodibenzo[b,e]thiepin-11(6H)-one
• Baloxavir Impurity 2